PISCATAWAY, N.J. -- Today, InterHealth distributed a news release stating that it has filed a law suit against Sabinsa Corporation for patent infringement on its niacin-bound chromium compound. Company president Todd Norton has issued the following statement:
"Sabinsa is a company recognized for its commitment to the development and protection of legitimate intellectual property, and we respect the rights of others who have made the same commitment. We encourage the industry as a whole to become greater advocates of this as well. As far as the issue at hand is concerned, the matter is being handled by our attorneys."